7
Views
15
CrossRef citations to date
0
Altmetric
Research

Section Review Central & Peripheral Nervous Systems: 5-HT3 receptor antagonists

&
Pages 471-481 | Published online: 29 Feb 2008
 

Abstract

Antagonists of the serotonin 5-HT3 receptor are clinically effective antinausea and anti-emetic drugs for the treatment of cancer patients undergoing chemotherapy and for patients undergoing procedures involving general anaesthesia. These compounds have also been evaluated for the treatment of irritable bowel syndrome, other painrelated disorders (including migraine) and a variety of central nervous system disorders (including anxiety, psychosis and the treatment of drug abuse). The status of research into potential clinical applications of these drugs is evaluated in this review. The evidence from preclinical and clinical studies is compared and avenues for future drug development using these compounds are discussed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.